Oramed Pharmaceuticals (ORMP) Notes Payables (2020 - 2025)
Oramed Pharmaceuticals' (ORMP) quarterly Notes Payables came in at $652000.0 in Q4 2025, up 98.18% YoY from $329000.0 in Q4 2024, and up 65100.0% on a QoQ basis from $1000.0 in Q3 2025.
Oramed Pharmaceuticals (ORMP) Notes Payables (2020 - 2025) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 6 years of Notes Payables data on file, last reported at $652000.0 in Q4 2025.
- Quarterly Notes Payables rose 98.18% year-over-year to $652000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $652000.0 (up 98.18% YoY) and the FY2025 annual result came in at $652000.0, up 98.18% from the prior year.
- Notes Payables climbed to $652000.0 in Q4 2025, from $1000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $51.0 million in Q4 2023 to a low of $1000.0 in Q2 2022.
- A 5-year average of $6.4 million and a median of $54000.0 in 2021 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2023 — Notes Payables jumped 5101200.0% — and 2025, when it tumbled 99.89%.
- Tracing ORMP's Notes Payables over 5 years: stood at $66000.0 in 2021, then tumbled by 98.48% to $1000.0 in 2022, then jumped by 5101200.0% to $51.0 million in 2023, then slumped by 99.36% to $329000.0 in 2024, then surged by 98.18% to $652000.0 in 2025.
- The last three Notes Payables figures came in at $652000.0 (Q4 2025), $1000.0 (Q3 2025), and $34000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 652,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 32.03 Mn |
| Dec 31, 2023 | 51.01 Mn |
| Sep 30, 2023 | 25.00 Mn |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 70,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Nov 30, 2021 | 66,000.00 |
| Aug 31, 2021 | 54,000.00 |
| Aug 31, 2020 | 90,000.00 |